arabia
middl
east
septemb
laboratoryconfi
rmed
case
may
report
detail
clinic
virolog
data
two
relat
case
merscov
diseas
nosocomi
transmiss
viru
one
patient
anoth
french
hospit
method
patient
visit
dubai
april
patient
live
franc
travel
abroad
patient
underli
immunosuppress
disord
test
specimen
upper
nasopharyng
swab
lower
bronchoalveolar
lavag
sputum
respiratori
tract
whole
blood
plasma
serum
specimen
merscov
realtim
rtpcr
target
upe
gene
merscov
find
initi
clinic
present
includ
fever
chill
myalgia
patient
patient
diarrhoea
induc
sputum
sampl
patient
wherea
nasopharyng
specimen
weakli
posit
inconclus
two
patient
share
room
day
incub
period
estim
day
second
case
secondari
transmiss
document
hospit
staff
despit
absenc
specifi
c
protect
measur
diagnosi
merscov
suspect
patient
die
may
due
refractori
multipl
organ
failur
interpret
patient
respiratori
symptom
return
middl
east
expos
confi
rmed
case
isol
investig
merscov
lower
respiratori
tract
sampl
analysi
assum
incub
period
day
immunosuppress
also
taken
account
risk
factor
coronavirus
larg
envelop
singlestrand
rna
virus
infect
caus
diseas
mani
anim
speci
includ
bat
mice
bird
dog
pig
cattl
human
be
fi
respiratori
coronavirus
describ
caus
common
cold
upper
respiratori
tract
infect
pneumonia
sar
septemb
novel
human
coronaviru
name
hcovemc
identifi
ed
two
patient
sever
respiratori
diseas
new
coronaviru
belong
lineag
c
genu
betacoronaviru
genet
close
relat
coronavirus
variou
bat
speci
africa
eurasia
may
laboratoryconfi
rmed
case
diagnos
sever
countri
franc
germani
jordan
qatar
saudi
arabia
tunisia
uk
patient
report
symptom
sever
respiratori
diseas
acut
renal
failur
case
fatal
rate
estim
case
origin
histori
travel
middl
east
except
two
secondari
case
uk
two
tunisia
one
franc
larg
cluster
case
document
hospit
saudi
arabia
anoth
suspect
basi
retrospect
analysi
sampl
kept
outbreak
respiratori
diseas
jordanian
hospit
april
basi
outbreak
dynam
hcovemc
renam
middl
east
respiratori
syndrom
coronaviru
merscov
intern
committe
taxonomi
virus
wherea
yet
unidentifi
ed
anim
reservoir
might
caus
initi
outbreak
introduc
viru
human
popul
occurr
cluster
whether
commun
hospit
worri
develop
might
result
adapt
viru
interhuman
transmiss
process
adapt
might
pivot
switch
abort
outbreak
intern
pandem
sarscov
report
detail
clinic
virolog
inform
two
relat
case
merscov
diseas
nosocomi
transmiss
viru
one
patient
anoth
french
hospit
april
report
data
two
patient
admit
hospit
april
may
northern
franc
medic
record
compil
review
attend
physician
spous
provid
written
inform
consent
data
sampl
use
research
report
purpos
extract
rna
specimen
upper
nasopharyng
swab
lower
bronchoalveolar
lavag
sputum
respiratori
tract
whole
blood
plasma
serum
specimen
use
nucleospin
dx
viru
nucleospin
rna
blood
mini
kit
machereynagel
gmbh
co
kg
franc
accord
manufactur
instruct
sputum
appli
pretreat
proteinas
k
mgml
min
digesteur
eurobio
coutaboeuf
franc
reduc
viscos
includ
sigma
viru
rna
ng
per
assay
control
extract
procedur
absenc
inhibitor
test
extract
nucleic
acid
realtim
rtpcr
assay
target
upe
region
merscov
genom
previous
describ
lightcycl
realtim
pcr
system
roch
coutaboeuf
franc
qualiti
specimen
assess
realtim
rtpcr
target
gapdh
housekeep
gene
posit
control
upe
realtim
rtpcr
invitro
transcrib
rna
combin
sequenc
gene
nucleotid
nucleotid
upe
gene
nucleotid
nucleo
tide
posit
strand
design
base
fi
rst
publish
sequenc
merscov
confi
rmatori
sequenc
analysi
rdrp
n
gene
region
describ
assembl
sequenc
use
clc
main
workbench
sponsor
studi
role
studi
design
data
collect
data
analysi
data
interpret
write
report
correspond
author
bg
svdw
full
access
data
studi
fi
nal
respons
decis
submit
public
patient
man
visit
dubai
april
april
fever
chill
diarrhoea
three
four
bowel
movement
per
day
start
april
symptom
much
previou
episod
sigmoid
treat
month
also
histori
hypertens
diabet
undergon
renal
transplant
renal
failur
secondari
diabet
exist
treatment
mycophenol
mofetil
ciclosporin
prednison
admit
valencienn
hospit
april
present
diarrhoea
fever
reach
arteri
pressur
mm
hg
pulseoxymetr
oxygen
satur
ambient
air
time
respiratori
symptom
cough
dyspnoea
chest
radiograph
normal
shown
tabl
summaris
biolog
data
patient
blood
cultur
stool
analysi
urin
antigen
assay
legionella
spp
pneumococcu
spp
plasma
pcr
cytomegaloviru
neg
treatment
ceftriaxon
initi
april
abdomin
ct
scan
done
april
show
evid
coliti
lower
thorac
imag
show
major
pulmonari
infi
ltrate
fi
gure
april
patient
develop
dyspnoea
cough
levofl
oxacin
ad
ceftriaxon
therapi
ct
scan
lung
done
april
show
mostli
peripher
interstiti
infi
ltrate
associ
right
lowerlob
consolid
left
lowerlob
consolid
anterior
basal
later
basal
posterior
basal
area
bronchoalveolar
lavag
done
cytolog
show
high
number
neutrophil
macrophag
specifi
c
pathogen
identifi
ed
direct
microbiolog
examin
bronchoalveolar
lavag
fl
uid
cotrimoxazol
ad
antimicrobi
treatment
regimen
oxygen
requir
increas
daili
reach
lmin
april
patient
transfer
douai
hospit
intensivecar
unit
icu
april
noninvas
mechan
ventil
start
antimicrobi
therapi
modifi
ed
piperacillin
plu
tazobactam
linezolid
rapid
respiratori
deterior
intub
april
fi
gure
respiratori
failur
follow
shock
renal
failur
lead
noradrenalin
administr
continu
venoven
haemofi
ltration
may
basi
clinic
present
histori
recent
travel
dubai
hypothesi
infect
mrescov
rais
prompt
transfer
nasopharyng
store
bronchoalveolar
lavag
sampl
nation
refer
center
pari
worsen
respiratori
statu
partial
pressur
oxygen
pao
fraction
inspir
oxygen
fio
ratio
despit
low
tidal
volum
highposit
end
expiratori
pressur
peep
ventil
inhal
nitric
oxid
prone
posit
sedat
neuromuscular
blockad
prompt
implement
extracorpor
membran
oxygen
ecmo
persist
haemodynam
support
norepinephrin
mgh
necessari
patient
transfer
ecmo
referr
centr
icu
lill
univers
teach
hospit
may
fi
gure
may
patient
remain
ecmo
therapi
persist
sever
acut
respiratori
distress
syndrom
fi
gure
fio
ecmo
ventil
set
mean
ecmo
pump
fl
ow
lmin
result
pao
valu
exceed
mm
hg
oxygen
sweep
fl
ow
lmin
result
mean
partial
pressur
carbon
dioxid
valu
mm
hg
patient
sever
haemorrhag
complic
contribut
renal
failur
requir
extraren
epur
evid
bacteri
superinfect
note
ecmo
endotrach
aspir
remain
steril
implant
ecmo
patient
candidemia
candida
albican
candida
glabrata
empir
antifung
therapi
caspofungin
start
ecmo
patient
die
may
due
refractori
multipl
organ
failur
patient
man
admit
valencienn
hospit
april
left
arm
deep
venou
thrombosi
live
north
franc
recent
travel
abroad
medic
histori
includ
myocardi
infarct
arteri
hypertens
dyslipidaemia
histamineinduc
angioedema
need
system
corticosteroid
therapi
prednison
mg
per
day
sinc
june
also
sever
episod
deep
venou
thrombosi
associ
presenc
low
concentr
anticardiolipin
antibodi
igm
isotyp
treat
vitamin
k
antagonist
patient
share
patient
room
april
april
room
separ
two
patient
bed
patient
share
bathroom
period
patient
remain
mostli
confi
ned
bed
wherea
patient
abl
move
around
nebulis
known
aerosolgener
procedur
use
patient
diagnosi
merscov
infect
suspect
patient
wore
mask
neither
patient
staff
visitor
use
protect
equip
patient
discharg
hospit
home
april
may
patient
present
asthenia
myalgia
cough
may
rapidli
direct
infecti
diseas
depart
lill
univers
teach
hospit
sinc
time
known
contact
confi
rmed
case
posit
result
merscov
avail
patient
may
admiss
present
fever
pulseoxymetr
satur
ambient
air
respiratori
rate
breath
per
min
tabl
summaris
biolog
data
patient
chest
radiograph
show
upper
right
lobe
consolid
fi
gure
oxygen
therapi
lmin
piperacillin
plu
tazobactam
start
april
initi
nasopharyng
sampl
inconclus
patient
remain
stabl
high
fever
may
may
linezolid
ad
anti
microbi
regimen
may
diagnosi
merscov
infect
confi
rmed
basi
result
induc
sputum
analysi
may
person
protect
equipmentan
mask
glove
gown
goggleswa
use
prevent
secondari
transmiss
sputum
induct
may
patient
acut
respiratori
failur
oxygen
therapi
increas
lmin
chest
radiograph
show
complet
consolid
right
lung
involv
lower
left
lobe
fi
gure
patient
transfer
icu
oxygen
therapi
progress
increas
appear
confus
disorient
increas
hypoxaemia
led
intub
mechan
ventil
may
bronchoalveolar
lavag
done
specifi
c
pathogen
identifi
ed
either
direct
microbiolog
examin
cultur
sampl
test
merscov
diagnosi
alreadi
confi
rmed
intub
day
fio
increas
inhal
nitric
oxid
prone
posit
becam
necessari
intub
dobutamin
introduc
biventricular
dysfunctionconfi
rmed
transthorac
echo
cardio
gramand
progress
wean
next
h
acut
renal
failur
anuria
despit
volum
expans
result
haemodialysi
may
may
pao
fio
ratio
despit
inhal
nitric
oxid
prone
posit
low
tidal
volum
high
peep
ventil
lead
impl
mentat
ecmo
neither
norepinephrin
dobuta
mine
treatment
underway
day
ecmo
implant
chest
radiograph
show
bilater
diff
use
alveolarinterstiti
infi
ltrate
may
fi
gure
chest
radiograph
also
show
bilater
groundglass
opac
major
consolid
fi
gure
bacteri
superinfect
identifi
ed
ecmo
patient
respiratori
statu
improv
sinc
may
fio
ventil
ecmo
set
ecmo
fl
ow
lmin
ecmo
oxygen
sweep
fl
ow
lmin
sedat
progress
wean
may
nation
infl
uenza
center
institut
pasteur
notifi
ed
french
institut
public
health
surveil
possibl
case
infect
merscov
nasopharyng
swab
obtain
patient
april
analys
realtim
rtpcr
preliminari
result
rtpcr
done
blood
specimen
patient
may
posit
merscov
whole
blood
weak
inconsist
detect
note
plasma
sampl
tabl
type
specimen
analys
either
patient
timefram
viru
isol
vero
african
green
monkey
kidney
cell
attempt
respiratori
specimen
patient
isol
obtain
sputum
patient
preliminari
analysi
serum
sampl
patient
may
may
show
reactiv
western
blot
recombin
n
protein
data
shown
confi
rmatori
sequenc
analysi
rdrp
n
gene
segment
done
directli
rna
extract
bronchoalveolar
lavag
specimen
patient
sputum
specimen
patient
sequenc
patient
ident
rdrp
sequenc
show
polymorph
posit
distinguish
avail
sequenc
isol
n
gene
sequenc
ident
emc
isol
show
short
delet
nucleotid
polymorph
record
posit
sequenc
found
posit
sequenc
appendix
result
defi
nitiv
estab
lish
patient
infect
merscov
report
describ
fi
rst
two
french
case
merscov
infect
case
patienttopati
nosocomi
transmiss
panel
fi
nding
suggest
viru
incub
period
could
reach
day
longer
period
previous
record
clinic
implic
durat
quarantin
result
also
suggest
best
sampl
detect
viru
lower
respiratori
tract
rather
nasopharyng
sampl
two
case
report
show
similar
clinic
featur
compar
two
case
detail
clinic
descript
avail
report
complet
clinic
data
initi
present
includ
fever
chill
myalgia
respiratori
symptom
cough
dyspnoea
soon
becam
predomin
clinic
symptom
rapid
deterior
oxygen
increas
oxygen
requir
lead
mechan
ventil
ecmo
later
cours
diseas
soon
icu
admiss
sever
renal
failur
anuria
need
renal
replac
therapi
develop
lympho
penia
anoth
common
featur
two
patient
also
note
report
zaki
colleagu
clinic
present
reminisc
patient
sever
sar
except
acut
renal
failur
seem
less
common
sar
case
fact
sarscov
associ
wide
spectrum
clinic
featuresinfect
peopl
present
initi
fever
myalgia
chill
rigor
subsequ
develop
pneu
monia
notabl
patient
diarrhoea
among
initi
symptom
featur
yet
report
patient
merscov
present
upon
admiss
quarter
patient
sar
patient
die
may
patient
remain
icu
ecmo
casefat
rate
patient
infect
merscov
highit
estim
patient
report
far
rate
higher
sar
estim
strongli
agedepend
whether
rate
higher
patient
merscov
see
onlin
appendix
search
pubm
may
term
hcovemc
merscov
articl
publish
english
search
identifi
ed
report
link
hcovemc
start
initi
report
zaki
colleagu
describ
previous
unknown
coronaviru
isol
sputum
man
articl
relev
paper
cite
text
search
merscov
identifi
ed
four
articl
none
relat
human
transmiss
clinic
fi
nding
report
provid
evid
patient
respiratori
symptom
histori
travel
middl
east
contact
known
merscov
case
past
day
isol
investig
use
lower
respiratori
tract
sampl
fi
nding
also
suggest
immunosuppress
aggrav
factor
could
associ
atyp
clinic
present
underreport
milder
form
diseas
higher
proport
patient
underli
immuno
suppress
disord
patient
higher
virul
merscov
compar
sarscov
yet
establish
two
patient
describ
merscov
detect
time
diagnosi
pneumonia
data
obtain
far
show
ident
sequenc
virus
infect
patient
sequenc
also
ident
avail
report
merscov
sequenc
whole
genom
sequenc
analysi
viral
popul
divers
need
establish
degre
variabl
virus
french
case
rel
previou
case
work
related
virus
two
patient
upon
transmiss
viral
load
high
sampl
obtain
lower
respiratori
tract
wherea
viru
almost
undetect
upper
respiratori
tract
sampl
besid
two
case
avail
data
confi
rmed
patient
shown
posit
detect
rtpcr
upper
respiratori
tract
specimen
day
symptom
onset
lower
respiratori
tract
specimen
day
symptom
onset
sputum
sampl
taken
day
symptom
onset
also
report
led
viru
isol
notabl
patient
london
case
report
septemb
nasal
throat
swab
neg
time
sputum
sampl
posit
littl
inform
avail
viru
shed
reminisc
sarscov
overal
viru
detect
rtpcr
lower
respiratori
tract
clinic
sampl
versu
upper
respiratori
tract
sampl
viral
load
signifi
cantli
higher
lower
respiratori
tract
compar
upper
respiratori
tract
upper
respiratori
tract
rate
viral
shed
initi
low
increas
peak
around
day
whether
merscov
present
outsid
respiratori
tract
requir
addit
studi
far
report
viru
detect
stool
urin
preliminari
data
suggest
viru
might
present
blood
sar
viru
readili
detect
stool
sampl
frequent
day
onset
symptom
wherea
blood
sampl
detect
frequent
earli
cours
ill
although
addit
data
kinet
rout
viral
shed
need
merscov
initi
data
suggest
possibl
suspect
case
especi
present
earli
onset
symptom
clinic
sampl
lower
respiratori
tract
obtain
confi
rmation
infect
confi
rmation
initi
neg
result
anoth
sampl
taken
day
later
recommend
exclus
possibl
case
patient
admit
april
time
pneumonia
alreadi
present
patient
merscov
present
bronchoalveolar
lavag
sampl
taken
day
although
result
avail
time
next
day
two
patient
share
room
specifi
c
isol
measur
standard
precaut
day
exposur
patient
develop
symptom
suggest
lower
respiratori
tract
infect
fi
gure
patient
infect
merscov
confi
rmed
day
later
induc
sputum
sampl
timefram
high
end
day
incub
period
report
two
secondari
case
uk
day
incub
period
sar
view
small
number
patient
welldefi
ned
window
exposur
merscov
avail
fi
nding
humantohuman
transmiss
exposur
upper
rang
report
incub
period
suggest
incub
period
beyond
day
might
possibl
merscov
import
implic
durat
quarantin
need
rule
infect
contact
furthermor
patient
recent
travel
abroad
exclud
sourc
contamin
howev
exact
rout
transmiss
patient
patient
remain
unclear
nosocomi
transmiss
merscov
suspect
patient
healthcar
worker
respiratori
symptom
jordan
april
ongo
hospit
outbreak
case
saudi
arabia
persontoperson
transmiss
document
one
patient
two
famili
member
uk
two
case
report
tunisia
sarscov
transmiss
larg
respiratori
droplet
current
thought
like
rout
merscov
transmiss
two
patient
describ
aerosolgener
procedur
use
patient
presenc
diarrhoea
patient
possibl
link
merscov
infect
previous
describ
sarscov
might
also
potenti
sourc
contamin
environ
systemat
detect
merscov
stool
futur
patient
might
import
document
shed
viru
faec
potenti
contribut
viral
transmiss
hospit
stay
valencienn
person
protect
equip
use
record
secondari
tran
mission
healthcar
worker
assess
develop
symptom
test
rtpcr
presenc
merscov
unpublish
similarli
patient
discharg
hospit
home
secondari
case
detect
contact
low
viru
shed
upper
respiratori
tract
might
contribut
reduc
transmi
sibil
although
serolog
investig
need
better
assess
extent
transmiss
lie
disord
immuno
suppress
treatment
two
patient
probabl
contribut
increas
suscept
infect
background
ad
list
criteria
associ
increas
suspicion
merscov
infect
risk
acquisit
mutat
merscov
might
becom
increasingli
transmiss
human
be
must
also
kept
mind
continu
assess
suggest
contributor
bg
af
svdw
jointli
wrote
report
bg
jp
lem
cs
ne
xl
fv
dm
involv
treatment
patient
clinic
manag
contact
ag
sb
vc
jcm
svdw
involv
laboratori
test
interpret
result
specimen
svdw
analysi
viral
sequenc
dc
involv
epidemiolog
investig
contributor
merscov
studi
team
particip
treatment
patient
clinic
manag
contact
epidemiolog
investig
virolog
analys
coauthor
provid
comment
approv
fi
nal
version
report
declar
confl
ict
interest
